Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-13 Sale |
2023-02-15 8:12 pm |
Icosavax Inc. | ICVX | Bekiroglu Elizabeth General Counsel & Corp. Sec. |
5,922 | $10.69 | $63,322 | 103,007 (Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 8:09 pm |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
7,506 | $10.69 | $80,259 | 1,034,681 (Indirect Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 8:07 pm |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
4,871 | $10.33 | $50,338 | 292,846 (Indirect Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 8:04 pm |
Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer |
1,902 | $10.69 | $20,337 | 48,686 (Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 7:58 pm |
Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer |
1,794 | $10.69 | $19,183 | 239,187 (Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 7:56 pm |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
1,660 | $10.69 | $17,750 | 156,847 (Direct) |
View |
| 2022-12-21 Sale |
2022-12-23 7:00 pm |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
66,764 | $8.963 | $598,406 | 1,062,641 (Indirect Direct) |
View |
| 2022-12-15 Sale |
2022-12-16 6:36 pm |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
19,648 | $11.14 | $218,963 | 296,050 (Indirect Direct) |
View |
| 2022-09-08 Sale |
2022-09-09 6:44 pm |
Icosavax Inc. | ICVX | Bekiroglu Elizabeth General Counsel & Corp. Sec. |
1,813 | $4.8731 | $8,835 | 108,929 (Direct) |
View |
| 2022-07-29 Sale |
2022-08-02 9:47 pm |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
11,377 | $6.75 | $76,795 | 1,081,509 (Indirect Direct) |
View |
| 2022-07-29 Sale |
2022-08-02 9:43 pm |
Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer |
2,959 | $6.75 | $19,973 | 48,921 (Direct) |
View |
| 2022-07-29 Sale |
2022-08-02 9:42 pm |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
10,375 | $6.6668 | $69,168 | 315,698 (Indirect Direct) |
View |
| 2022-07-29 Sale |
2022-08-02 9:40 pm |
Icosavax Inc. | ICVX | Richardson Charles E SVP, Technical Operations |
2,218 | $6.7501 | $14,972 | 165,168 (Direct) |
View |
| 2022-07-29 Sale |
2022-08-02 9:37 pm |
Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer |
3,245 | $6.7501 | $21,904 | 239,314 (Direct) |
View |
| 2022-07-29 Sale |
2022-08-02 9:34 pm |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
1,812 | $6.75 | $12,231 | 131,738 (Direct) |
View |
| 2022-04-01 Purchase |
2022-04-05 4:10 pm |
Icosavax Inc. | ICVX | MCDADE MARK Director |
42,225 | $7.1 | $299,798 | 3,560,471 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-15 Option Award |
2023-02-17 7:08 pm |
N/A 2033-02-14 |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 7:06 pm |
N/A 2033-02-14 |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 7:03 pm |
N/A 2033-02-14 |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
350,000 | $0 | 350,000 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-16 8:00 pm |
N/A N/A |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
10,677 | $1.04 | 1,462,608 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-16 8:00 pm |
N/A 2031-01-28 |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
10,677 | $0 | 1,462,608 (Direct) |
View |
| 2022-05-31 Ownership |
2023-02-14 5:22 pm |
N/A N/A |
Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer |
1,667 | $5.77 | 50,588 (Direct) |
View |
| 2022-05-31 Ownership |
2023-02-14 5:19 pm |
N/A N/A |
Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer |
1,667 | $5.77 | 240,981 (Direct) |
View |
Ownership |
2023-02-14 5:15 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
0 | $0 | 297,717 (Indirect) |
View |
| 2022-05-31 Ownership |
2023-02-14 5:15 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
1,667 | $5.77 | 297,717 (Direct) |
View |
| 2022-05-31 Ownership |
2023-02-14 5:02 pm |
N/A N/A |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
1,667 | $5.77 | 158,507 (Direct) |
View |
| 2023-01-30 Exercise |
2023-01-31 4:19 pm |
N/A N/A |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
25,102 | $0.84 | 159,351 (Direct) |
View |
| 2023-01-30 Exercise |
2023-01-31 4:19 pm |
N/A 2029-12-01 |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
25,102 | $0 | 159,351 (Direct) |
View |
| 2023-01-25 Exercise |
2023-01-27 5:02 pm |
N/A N/A |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
2,395 | $0.84 | 1,501,246 (Direct) |
View |
| 2023-01-25 Exercise |
2023-01-27 5:02 pm |
N/A N/A |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
10,678 | $1.04 | 1,501,246 (Direct) |
View |
| 2023-01-25 Exercise |
2023-01-27 5:02 pm |
N/A 2030-05-10 |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
13,073 | $0 | 1,501,246 (Direct) |
View |
| 2022-12-23 Exercise |
2022-12-23 7:00 pm |
N/A N/A |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
14,369 | $0.84 | 1,062,641 (Direct) |
View |
| 2022-12-23 Exercise |
2022-12-23 7:00 pm |
N/A 2030-05-10 |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
14,369 | $0 | 1,062,641 (Direct) |
View |
| 2022-11-10 Option Award |
2022-11-14 7:08 pm |
N/A 2032-11-09 |
Icosavax Inc. | ICVX | Bekiroglu Elizabeth General Counsel & Corp. Sec. |
88,900 | $0 | 88,900 (Direct) |
View |
| 2022-11-10 Option Award |
2022-11-14 7:05 pm |
N/A 2032-11-09 |
Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-11-10 Option Award |
2022-11-14 6:58 pm |
N/A 2032-11-09 |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
82,580 | $0 | 82,580 (Direct) |
View |
| 2022-11-10 Option Award |
2022-11-14 6:53 pm |
N/A 2032-11-09 |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-11-10 Option Award |
2022-11-14 6:50 pm |
N/A 2032-11-09 |
Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer |
82,580 | $0 | 82,580 (Direct) |
View |
| 2022-11-10 Option Award |
2022-11-14 6:43 pm |
N/A 2032-11-09 |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
277,146 | $0 | 277,146 (Direct) |
View |
| 2022-02-18 Gift |
2022-08-02 9:42 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
20,000 | $0 | 315,698 (Indirect) |
View |
| 2022-07-01 Exercise |
2022-07-06 6:53 pm |
N/A N/A |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
7,185 | $0.84 | 1,140,781 (Direct) |
View |
| 2022-07-01 Exercise |
2022-07-06 6:53 pm |
N/A 2030-05-10 |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
7,185 | $0 | 1,140,781 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:10 pm |
N/A 2032-06-09 |
Icosavax Inc. | ICVX | Wassil Jim Director |
55,643 | $0 | 55,643 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:07 pm |
N/A 2032-06-09 |
Icosavax Inc. | ICVX | Veneman Ann M Director |
27,821 | $0 | 36,321 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:03 pm |
N/A 2032-06-09 |
Icosavax Inc. | ICVX | Shiver John W. Director |
12,042 | $0 | 20,542 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:01 pm |
N/A 2032-06-09 |
Icosavax Inc. | ICVX | FIELDS HEIDI Director |
27,821 | $0 | 36,571 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 4:30 pm |
N/A 2032-06-09 |
Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
27,821 | $0 | 5,991,386 (Indirect) |
View |
| 2022-06-10 Option Award |
2022-06-14 4:12 pm |
N/A 2032-06-09 |
Icosavax Inc. | ICVX | MCDADE MARK Director |
27,821 | $0 | 3,588,292 (Direct) |
View |